Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Curcumin - Theravalues

Next Previous
X
Search
Drug Profile

Curcumin - Theravalues

Alternative Names: CR-011L; Curcumin nanoparticles; Theracurmin; Theracurmin CR-011L

Latest Information Update: 11 Dec 2021

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Theravalues Corporation
  • Class Anti-ischaemics; Antihistamines; Antivirals; Catechols; Chemopreventatives; Nonsteroidal anti-inflammatories; Small molecules
  • Mechanism of Action Immunosuppressants; Thromboxane synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Chronic obstructive pulmonary disease; Left ventricular hypertrophy
  • Phase I/II Cognition disorders
  • No development reported Cancer; Pancreatic cancer

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Cancer in USA (PO, Liquid)
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Pancreatic-cancer(Second-line therapy or greater) in USA (PO, Liquid)
  • 01 Oct 2017 Theravalues completes a phase I/II trial in Cognition disorders in USA (PO) (NCT02104752)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top